Needles Market Estimated to Experience a Hike in Growth by 2035

The prevalence of chronic conditions, including diabetes, autoimmune diseases, heart diseases, and cancer, has escalated significantly over the years. These conditions are now recognized globally as major contributors to mortality and disability.

For centuries, medical needles have been essential tools in healthcare, utilized for a wide range of procedures, including drug delivery, dental and surgical interventions, vaccine administration, and blood or specimen collection. Their precision and effectiveness in delivering targeted treatments and facilitating diagnostic processes have established them as a cornerstone of the healthcare industry.
The global needles market size is projected to grow from $8.1 billion in 2025 to $14.7 billion by 2035, representing a CAGR of 6.1% during the forecast period.

It is worth mentioning that the number of partnerships inked in this domain has increased over time at a CAGR of 40%, since 2020. Most of the deals (2 were instances of acquisitions, enabling the players to expand their business and making their products widely accessible to the customers; examples include (in reverse chronological order, inked in 2024) acquisition of Takeda Pharmaceutical by Corza Medical (July 2024), Allmed Medical Care by Alta Semper Capital (June 2024), Sunrise Medical by Platinum Equity (June 2024), Healthium Medtech by KKR (May 2024), and SAM Medical by Tri Tech Forensics (May 2024). Other prominent types of partnership models adopted by stakeholders in this domain include commercialization agreements (8) and distribution agreements (7).

In addition, players based in North America have signed the maximum number of collaborations; of which, 19 are intracontinental agreements and 9 are intercontinental agreements. Further, most of the players based in North America signed intercontinental agreements with stakeholders headquartered in Asia-Pacific and Rest of the world-based (six), followed by stakeholders headquartered in Europe (four). Examples of recent intracontinental deals signed with players based in North America include (in reverse chronological order, headquartered in Canada) Boston Scientific and Baylis Medical Technologies (February 2022), and Montméd and Roche (January 2021).

Close to 760 patents have been filed / granted focussed on needles by industry and non-industry players to protect intellectual property generated within needles domain. the majority (48%) of the patents were published in 2022, followed by patents published in 2023 (40%). This decrease in the number of patents published in 2023 is indicative of the growing preference for alternative non-invasive routes of drug delivery, such as oral, topical and nasal routes. Additionally, around 12% of the patents in this domain have been published post-2023.

In addition to this, majority (48%) of the limited patents were published in 2022, followed by those published in 2023 (44%). This is an indicative of static patent activity for needles, owing to the stringent regulatory requirements and quality standards that can significantly complicate the development and approval processes for new needles. However, the continuous expansion of needles market is anticipated to drive patent filings as companies strive to differentiate their product portfolio to meet healthcare needs.

Research Methodology
Our analysts have performed an accurate examination of the various aspects of the global market leveraging avant-garde primary and secondary sources of data collection. The report has gathered the necessary data and information from several reliable sources. Additionally, the report offers many strategic recommendations for companies involved in this ever-growing business sector to help them attain a competitive edge in the Needles Market.

Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.

Read More :- https://www.rootsanalysis.com/....reports/needles-mark

Oncology Precision Medicine Market Key Highlights and Future Opportunities Till 2035

The new market research report titled ‘Oncology Precision Medicine market’, published by Roots Analysis offers a comprehensive study of the Oncology Precision Medicine Market, while estimating the overall market size and the size and share of the key regional segments of the global market over historical period, as well as the projected timeline till 2035.

The global oncology precision medicine market size is estimated to grow from USD 147.9 billion in 2024 to USD 364 billion by 2035, representing a CAGR of 8.5% during the forecast period till 2035. The anticipated market growth is accredited to the significant surge in demand across the regional and global markets for the products and services offered by the Oncology Precision Medicine Market. The latest study provides readers with a granular analysis of the major developmental elements of the global market, potential business avenues, and the overall market dynamics. The report has been specially curated to offer a deep understanding of the competitive terrain of the global market, highlighting the leading market rivals, their market positions, product portfolios, gross revenue shares, profit margins, pricing analysis, sales network & distribution channels, and financial standing.

Type of Cancer Targeted
Bladder Cancer
Blood / Hematologic Cancer
Breast Cancer
Cervical Cancer
Gastrointestinal Cancer
Head and Neck Squamous Cell Cancer
Lung Cancer
Skin Cancer
Others

Route of Administration
Oral
Intravenous
Others
Type of Molecule
Small Molecules
Biologics

Key Geographical Regions
North America (US, Canada)
Europe (France, Germany, Italy, Spain and UK)
Asia (China, Japan, Korea and India)
Middle East and North Africa (UAE, Israel, Qatar and Rest of Middle East and North Africa)
Latin America (Brazil, Argentina, Chile and Rest of Latin America)

The latest research report specializes in the in-depth analysis of the macroeconomic and microeconomic factors affecting the Oncology Precision Medicine Market development. The report also concentrates on the regulatory framework that is shaping the future of the global market. New and existing pricing structures, emerging application areas, and upcoming investment opportunities have also been detailed in the report. The report further studies the projected growth factors that are expected to influence the market dynamics over the forecast timeframe.

The study is inclusive of a comprehensive analysis of the commonly used marketing and promotional strategies adopted by the key market players. Taking into account the existing market development factors, historical events, and recent market trends, the study presents a balanced opinion on the future scenario of the Oncology Precision Medicine Market. It thus supports its opinion by discussing the key corporate strategies, such as mergers & acquisitions, takeovers, joint ventures, and strategic alliances, used by the market players to strengthen their global footprint.

Research Methodology
Our analysts have performed an accurate examination of the various aspects of the global market leveraging avant-garde primary and secondary sources of data collection. The report has gathered the necessary data and information from several reliable sources. Additionally, the report offers many strategic recommendations for companies involved in this ever-growing business sector to help them attain a competitive edge in the Oncology Precision Medicine Market.


Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.

To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/oncology-pre

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide.

Contact:
Roots Analysis
+1 (415) 800 3415
Sales@rootsanalysis.com

Single Use Downstream Bioprocessing Market Growth Prospects, Developments Plans, Future Insights and Trends Analysis Till 2035

The latest report entitled ‘Single use downstream bioprocessing Market’ by Roots Analysis provides an accurate estimation of the market size, regional landscape description, and revenue forecast over the projected timeframe.

The single use downstream bioprocessing market is estimated to be worth $1.14 billion and is expected to grow at compounded annual growth rate (CAGR) of 15.0% during the forecast period. The report turns the spotlight on the major challenges faced by the key players in the global market and the growth strategies currently adopted by them. The report is a granular assessment of this particular business sphere and entirely covers the dynamic competitive landscape of the market. The document offers key insights into the market positions of these players alongside their gross earnings. Furthermore, it elaborates on each of the market segments, with detailed scrutiny of the development scope and competitive scenario of the regional fragments of the market.

The latest study is inclusive of an in-depth analysis of the economic status of the Single use downstream bioprocessing Market and examines the most important regions constituting the global market. It further details on the most lucrative and growth-oriented regions, top market rivals, diversified product types, and a large number of end-use industries.

Key factors affecting the growth of the Single use downstream bioprocessing Market:
Geographical Overview:
• The latest report broadly categorizes the Single use downstream bioprocessing Market into several geographical terrains, including North America, Europe, Asia-Pacific, MENA, Latin America, and Rest of the World.
• The study is inclusive of essential information relevant to each region in this broad industry segment, along with the key drivers of the regional market growth.
• The report further estimates the revenue accumulated by these regions over the forecast period.

Competitive Hierarchy:
• The latest research report studies the major market players, their regional presence, industry share, and production facilities.
• The report offers significant data pertaining to these market competitors’ company profiles, product types, and application outlook.
• Moreover, the pricing models and gross margins of these industry majors have also been mentioned in the report.

Key players
3M, Agilitech, CPC (Colder Products Company), Cytiva Lifesciences, Pall Corporation, Pneumatic Scale Angelus and Thermo Fisher Scientific.

Additional parameters of the Single use downstream bioprocessing Market report:
• The latest research study endows the reader with a comprehensive analysis of the product types of the Single use downstream bioprocessing Market, categorizing the relevant information into the Distribution by Type of Product (Single-use Chromatography Systems, Single-use Filtration Systems, Single-use Sampling Systems and Single-use Connectors), Scale of Operation (Preclinical / Clinical and Commercial) and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin-America, Middle East and North Africa and Rest of the World). The study focuses on the wide-ranging application landscape of the market, segmenting it into the market share, estimated growth rate, and the forecast product demand for each application type.

Additional Insights:
• The market concentration rate and processing rate of raw materials have also been conscripted in the report.
• The report contains an assessment of the current price trends, as well as the factors influencing the global market size.
• It throws light on the significant marketing strategies implemented by the eminent players in the industry.
• Vital data and information concerning the producers, distributors, and downstream buyers involved in the global market, as well as the cost structure analysis and market mechanism, form the important elements of this report.

Research objectives:
• The Single use downstream bioprocessing Market report studies the worldwide market consumption rate in terms of value and volume.
• It identifies the various sub-segments of the market structure.
• It proffers information regarding the leading global manufacturers in this industry, describing their market value & share, sales volume, competitive analysis, SWOT analysis, and development strategies adopted during the forecast timeline.
• The report describes the key industry players, with respect to their individual growth trends, future prospects, and contribution to the global market, and explains the factors related to their market growth potential, drivers, opportunities, threats, and industry-specific challenges.
• Furthermore, the report underpins the strategic developments occurring in the Single use downstream bioprocessing Market, such as expansions, mergers & acquisitions, agreements, as well as new product launches.

To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/single-use-d

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide.

Contact:
Roots Analysis
+1 (415) 800 3415
Sales@rootsanalysis.com

Mesothelioma Lung Cancer Attorneys Mesothelioma attorneys specialize in asbestos-related lawsuits filed by asbestos victims. These lawsuits offer compensation to patients and their families for medical treatment, caregiving and funeral costs. Attorneys like Chris Panatier focus on holding asbestos companies responsible for the harm they cause. His commitment to this goal has led to several headline-grabbing jury verdicts for his clients. They operate on a per-contingency basis. Many mesothelioma sufferers and their families do not have the fu